10th Annual Southern California Kidney Symposium: The Current and Future State of Renal Replacement Therapies

Friday, June 5, 2026, 7:15 AM - 4:30 PM, HSC Conference Center- USC Health Sciences Campus, Los Angeles, CA

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

Pre-registration for this program closes on May 29, 2026 at 12pm. To register after 12pm on May 29, 2026, please register on-site at the conference on Friday, June 5, 2026 starting at 7:15 am. Thank you!

This 10th Annual Southern California Kidney Symposium focuses on "The Current and Future State of Renal Replacement Therapies." This live educational activity brings together nationally and internationally recognized experts to review advances across the full spectrum of kidney replacement therapy, including dialysis, transplantation, health policy, and emerging technologies.

The program will highlight innovations in hemodialysis and peritoneal dialysis, including advances in membrane technology and expanded indications for extracorporeal therapies. Sessions will also explore contemporary issues in kidney transplantation, including organ allocation, living donation, long-term graft management, and xenotransplantation.

In addition, the symposium will address evolving payment models policy changes impacting kidney care delivery, including value-based care and Medicare Advantage. Finally, participants will gain insight into cutting-edge developments in kidney replacement, including regenerative medicine, stem cell therapies, and bioartificial kidney technologies.

This course is designed to provide clinicians with practical, evidence-based updates and a forward-looking perspective on the future of renal replacement therapy.

1. Compare emerging dialysis modalities, including high-flux hemodialysis, hemodiafiltration, and extended dialysis techniques.
2. Describe recent innovations in peritoneal dialysis and their implications for patient outcomes and modality utilization.
3. Evaluate expanded applications of extracorporeal therapies beyond kidney failure, including use in sepsis and liver failure.
4. Review advances in kidney transplantation, including organ allocation, living donation strategies, and long-term graft management.
5. Know the current state and future potential of xenotransplantation.
6. Analyze the impact of evolving healthcare policies, including value-based care models and Medicare Advantage, on nephrology practice and dialysis care delivery.
7. Identify emerging technologies in kidney replacement, including stem cell therapies and bioartificial kidney development.
8. Apply insights from innovations in renal replacement therapies to improve patient-centered care and clinical outcomes.

Pre-registration for this program closes on May 29, 2026 at 12pm. To register after 12pm on May 29, 2026, please register on-site at the conference on Friday, June 5, 2026 starting at 7:15 am. Thank you!

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 7.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy
Cancellations must be received by the USC Office of CME by email only by May 29, 2026 at 12:00pm PDT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, June 5, 2026